Lv1
40 积分 2025-10-10 加入
Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial
17天前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
20天前
已完结
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled study
1个月前
已完结
Treatment of pediatric epilepsy
1个月前
已完结
Epilepsy
1个月前
已完结
Epidermolysis bullosa
1个月前
已完结
Epilepsy in adults
1个月前
已完结
PONV Management in Adult Patients: Evidence-based Summary
3个月前
已完结
Update PONV – Was gibt es Neues bei der Prophylaxe und Therapie von postoperativer Übelkeit und postoperativem Erbrechen?
3个月前
已完结
A Randomized, Double-Blind Comparison of the NK1 Antagonist, Aprepitant, Versus Ondansetron for the Prevention of Postoperative Nausea and Vomiting
4个月前
已完结
皖公网安备34019202002308
